Hematologic effects of flt3 ligand in vivo in mice - PubMed (original) (raw)
. 1996 Sep 15;88(6):2004-12.
Affiliations
- PMID: 8822919
Free article
Hematologic effects of flt3 ligand in vivo in mice
K Brasel et al. Blood. 1996.
Free article
Abstract
We have investigated the effects of in vivo treatment with flt3 ligand (FL) on murine hematopoiesis, including mobilization of progenitors into the peripheral blood (PB). Mice were injected once daily with 10 micrograms recombinant human FL for 15 days. On days 3, 5, 8, 10, 15, and 22, mice were killed and analyzed for the number of leukocytes and colony-forming units (CFU) in bone marrow (BM), spleen, and PB. Splenic and PB cellularity increased with time in FL-treated mice. In the spleen, there was an increase in B cells, myeloid cells, and nucleated erythroid cells; in the PB, there was an increase in lymphocytes, granulocytes, and monocytic cells. The maximal number of CFU in the BM was observed after 3 days of FL treatment, giving 3.7- and 7.3-fold increases in CFU-granulocyte-macrophage (CFU-GM) and CFU-granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM), respectively, compared with mouse serum albumin (MSA)-treated controls. After 8 days of FL treatment, there was a maximal 123- and 108-fold increase in splenic CFU-GM and CFU-GEMM, respectively. The maximal number CFU-GM and CFU-GEMM were seen in PB on day 10, with 537- and 585-fold increases, respectively. Burst-forming units-erythroid (BFU-E) increased in the same time frame as those of CFU-GM and CFU-GEMM in BM, spleen, and PB, although the magnitude was not as great. Primitive day-13 CFU-spleen (CFU-S) and phenotypically defined stem cells were also mobilized into the PB of FL-treated mice with similar kinetics and magnitude to that of CFU-GM and CFU-GEMM. We conclude from these studies that FL, when administered as a single agent, is a potent mobilizer of hematopoietic progenitors into the PB.
Similar articles
- Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, et al. Gabbianelli M, et al. Blood. 1995 Sep 1;86(5):1661-70. Blood. 1995. PMID: 7544638 - Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG. Drexler HG. Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review. - FLT3: receptor and ligand. Biology and potential clinical application.
Shurin MR, Esche C, Lotze MT. Shurin MR, et al. Cytokine Growth Factor Rev. 1998 Mar;9(1):37-48. doi: 10.1016/s1359-6101(97)00035-x. Cytokine Growth Factor Rev. 1998. PMID: 9720755 Review.
Cited by
- Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models.
Clappaert EJ, Kancheva D, Brughmans J, Debraekeleer A, Bardet PMR, Elkrim Y, Lacroix D, Živalj M, Hamouda AEI, Van Ginderachter JA, Deschoemaeker S, Laoui D. Clappaert EJ, et al. Front Immunol. 2023 Aug 9;14:1166180. doi: 10.3389/fimmu.2023.1166180. eCollection 2023. Front Immunol. 2023. PMID: 37622122 Free PMC article. - Acute effects of FLT3L treatment on T cells in intact mice.
Wolf G, Gerber AN, Fasana ZG, Rosenberg K, Singh NJ. Wolf G, et al. Sci Rep. 2022 Nov 14;12(1):19487. doi: 10.1038/s41598-022-24126-4. Sci Rep. 2022. PMID: 36376544 Free PMC article. - The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy.
Cueto FJ, Sancho D. Cueto FJ, et al. Cancers (Basel). 2021 Mar 26;13(7):1525. doi: 10.3390/cancers13071525. Cancers (Basel). 2021. PMID: 33810248 Free PMC article. Review. - Mobilized peripheral blood: an updated perspective.
Karpova D, Rettig MP, DiPersio JF. Karpova D, et al. F1000Res. 2019 Dec 20;8:F1000 Faculty Rev-2125. doi: 10.12688/f1000research.21129.1. eCollection 2019. F1000Res. 2019. PMID: 32025285 Free PMC article. Review. - Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche.
de Kruijf EFM, Fibbe WE, van Pel M. de Kruijf EFM, et al. Ann N Y Acad Sci. 2020 Apr;1466(1):24-38. doi: 10.1111/nyas.14059. Epub 2019 Apr 21. Ann N Y Acad Sci. 2020. PMID: 31006885 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous